New York Mortgage Trust Azioni (NASDAQ: NYMT)

Ultime notizie per New York Mortgage Trust (NASDAQ:NYMT) Azioni

New York Mortgage Trust

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.

New York Mortgage Trust, Inc. - Common Stock

New York Mortgage Trust Inc

New York Mortgage Trust, Inc. - 9.125% Senior Notes Due 2029

New York Mortgage Trust, Inc. - 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.01 par value per share

New York Mortgage Trust, Inc. - 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

New York Mortgage Trust, Inc. - 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

New York Mortgage Trust, Inc. - 7.000% Series G Cumulative Redeemable Preferred Stock, $0.01 par value per share

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommends holding onto International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) or buy some. 
&#8220;I think IBM's doing a great job,&#8221; the Mad Money host added.
On July 24, IBM reported quarterly earnings of $2.43 per share, which beat the analyst consensus estimate of $2.19. Quarterly sales clocked in at $15.8 billion, which beat the analyst consensus estimate of $15.616 billion.
Cramer also recommended holding on to ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>). &#8220;I think it's Zim's time still,&#8221; he noted.
On Aug. 20, Jefferies analyst Omar Nokta maintained ZIM Integrated Shipping with a Buy and raised the price target from $22 to $25.
When asked about PJT Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>), he said, &#8220;It's a dice roll. I can't find out a lot about it. I have to be more certain about a company before I can opine it on this show.&#8221;
On July 30, PJT Partners posted better-than-expected quarterly results. PJT Partners reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $360.181 million which beat the analyst consensus estimate of $281.995 million.
What To Avoid: Cramer recommended not buying New York Mortgage Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) after the firm posted weaker-than-expected<a href="https://www.benzinga.com/quote/NYMT/analyst-ratings"> results for the second quarter</a> on July 31. 
NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) is a company that doesn't make money, Cramer said. 
&#8220;I know that we all want to play nuclear energy as a way to be able to get cheaper power for the data centers. I'm not going to recommend Nano as the way to do it,&#8221; he added.
On Aug. 20, Nano Nuclear Energy announced the purchase of 14,000 square-foot facility for $1.71 million.
Price Action:
<ul>
<li>New York Mortgage shares gained 0.8% to settle at $6.44 on Wednesday.</li>
<li>Zim shares fell 3.3% to close at $21.80.</li>
<li>PJT Partners shares gained 1.4% to settle at $123.34 on Wednesday.</li>
<li>NANO Nuclear Energy shares gained 2.7% to close at $11.20 during Wednesday's session.</li>
<li>IBM shares rose 0.6% to close at $197.21 on Wednesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40496479/around-1-5m-bet-on-this-real-estate-stock-check-out-these-3-stocks-insiders-are-buying">Around $1.5M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying</a></li>
</ul>

Long Ideas

News

Markets

Media

Trading Ideas

NYMT

IBM Is Doing A 'Great Job,' Jim Cramer Says — But Don't Buy This Real Estate Stock

Janney Montgomery Scott analyst Jason Stewart initiates coverage on New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Neutral rating.

Initiation

Analyst Ratings

Janney Montgomery Scott Initiates Coverage On New York Mortgage Trust with Neutral Rating

New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $0.01 by 3000 percent. The company reported quarterly sales of $19.044 million which missed the analyst consensus estimate of $23.479 million by 18.89 percent. This is a 25.82 percent increase over sales of $15.136 million the same period last year.

Earnings

Earnings Misses

New York Mortgage Trust Q2 2024 GAAP EPS $(0.29) Misses $0.01 Estimate, Sales $19.044M Miss $23.479M Estimate

Offerings

New York Mortgage Trust Files For Mixed Shelf Of Up To $300M

UBS analyst Douglas Harter maintains New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Neutral and lowers the price target from $7.5 to $6.

Price Target

UBS Maintains Neutral on New York Mortgage Trust, Lowers Price Target to $6

Keefe, Bruyette &amp; Woods analyst Bose George maintains New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Market Perform and lowers the price target from $8.5 to $7.

Keefe, Bruyette & Woods Maintains Market Perform on New York Mortgage Trust, Lowers Price Target to $7

WIIM

New York Mortgage Trust shares are trading lower after the company reported worse-than-expected Q1 financial results.

New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $0.10 by 850 percent. This is a 781.82 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $17.863 million which missed the analyst consensus estimate of $24.285 million by 26.44 percent. This is a 0.35 percent increase over sales of $17.801 million the same period last year.

New York Mortgage Trust Q1 2024 GAAP EPS $(0.75) Misses $0.10 Estimate, Sales $17.863M Miss $24.285M Estimate

B. Riley Securities analyst Matt Howlett reiterates New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Buy and lowers the price target from $15 to $11.

Reiteration

B. Riley Securities Reiterates Buy on New York Mortgage Trust, Lowers Price Target to $11

B. Riley Securities analyst Matt Howlett maintains New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Buy and lowers the price target from $15 to $11.

B. Riley Securities Maintains Buy on New York Mortgage Trust, Lowers Price Target to $11

New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
New York Mortgage Trust beat estimated earnings by 1650.0%, reporting an EPS of $0.35 versus an estimate of $0.02.
Revenue was down $5.50 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $1.14 which was followed by a 1.26% drop in the share price the next day.
Here's a look at New York Mortgage Trust's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.10</td>
<td>0.11</td>
<td>0.02</td>
<td>0</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.04</td>
<td>-0.41</td>
<td>0.11</td>
<td>-0.52</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>18.62M</td>
<td>23.32M</td>
<td>25.88M</td>
<td>20.75M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>16.79M</td>
<td>15.14M</td>
<td>17.80M</td>
<td>22.30M</td>
</tr>
</tbody>
</table>

To track all earnings releases for New York Mortgage Trust <a href="https://www.benzinga.com/quote/NYMT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

New York Mortgage Trust: Q4 Earnings Insights

New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.02 by 1650 percent. The company reported quarterly sales of $16.80 million which missed the analyst consensus estimate of $21.07 million by 20.26 percent. This is a 24.65 percent decrease over sales of $22.30 million the same period last year.

Earnings Beats

New York Mortgage Trust Q4 2023 GAAP EPS $0.35 Beats $0.02 Estimate, Sales $16.80M Miss $21.07M Estimate

ACVA

ALIT

AMSF

ANSS

ATNI

BALY

BELFA

BELFB

BLCO

BRDG

BROS

BRSP

CAKE

CCAP

CCRN

CCSI

CENX

CHDN

CHRD

CNNE

COKE

CSTE

CSTM

DINO

DOCN

ECPG

ERII

ESEA

ETSY

EXAS

FIVN

GATO

GKOS

GLBE

GOOD

GRMN

GSHD

ICLR

INSG

IONS

JACK

JOBY

KALU

LANV

LCID

LIVN

LUNG

MATV

MGRC

MTLS

NDSN

NEXA

NGVT

NOVA

NVDA

NVRO

OBDC

Earnings Scheduled For February 21, 2024

The U.S. housing market faces increased pressure as the average contract interest rate for 30-year fixed-rate mortgages rose by seven basis points to 6.87%, a peak not seen in <a href="https://www.benzinga.com/real-estate">the past two months.</a>
This rise in mortgage rates, as reported by the Mortgage Bankers Association (MBA) on Wednesday, is a direct consequence of a slew of robust economic data and stickier-than-expected inflation, which have pushed long-term benchmark Treasury yields higher.
Amid these rising rates, the mortgage sector has experienced a downturn in activity, indicating the rising cost of borrowing for prospective homeowners. This was evidenced by a 2.3% decrease in mortgage applications, a notable pullback from the 3.7% gain observed in the preceding week. 
Chart: Mortgage Rates Saw A New Uptick Last Week
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1024x495.png" alt="" class="wp-image-215751" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">January&#8217;s Inflation Surprised To The Upside, Yields Rise</h2>
In January, the U.S. annual inflation rate was 3.1%, slowing down from December&#8217;s 3.4% print but coming in above expectations of 2.9%. The monthly rise in the Consumer Price Index (CPI) basket was also higher than expected (0.3% vs. 0.2%).
Particularly alarming was the core inflation rate, excluding volatile energy and food prices, which held firm at 3.9% year-on-year in January, surpassing the anticipated 3.7%.
Read also: <a href="https://www.benzinga.com/markets/equities/24/02/37105400/magnificent-7-lose-more-than-250-billion-as-blazing-inflation-data-triggers-market-sell-off">Magnificent 7 Lose More Than $250 Billion As Blazing Inflation Data Triggers Market Sell-Off</a>
The bond market, which plays a critical role in setting mortgage rates, reacted sharply to the inflation data. The yields on 10-year and 30-year Treasuries climbed to 4.30% and 4.47%, respectively, on Tuesday, echoing levels last seen in early December 2023, reflecting growing investor apprehension towards a resumption of inflationary pressures. 
Chart: 30-Year Treasury Yields Nears 4.5%, The Highest Since Late November
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1024x495.png" alt="" class="wp-image-215754" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Traders Trim Rate Cut Bets, Mortgage-Related Stocks Sink</h2>
Market speculators have adjusted their expectations regarding Federal Reserve rate cuts, now anticipating less than a full percentage point of cumulative reductions by December 2024—a significant revision from the 175 basis points anticipated just a month earlier.
Following the inflation report and the bond market&#8217;s response, the real estate sector emerged as one of the most adversely affected, with the Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) experiencing a 1.8% decline on Tuesday, reaching monthly lows. 
Similarly, the mortgage industry, as tracked by the iShares Mortgage Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REM#NYSE">REM</a>), plummeted by 3.9%, marking its lowest point since mid-November 2023.
Among the most impacted stocks were Claros Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>), which saw an over 8% drop, Ares Commercial Real Estate Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>), down by 7.8%, and New York Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NYSE">NYMT</a>), which fell by 6.3%.
Chart: Mortgage Real Estate Stocks Have Retraced More Than Half Of The Oct-Dec Rally
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1024x495.png" alt="" class="wp-image-215767" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37099227/economists-sound-alarm-on-inflations-stubborn-grip-no-chance-inflation-will-return-">Economists Sound Alarm On Inflation&#8217;s Stubborn Grip: &#8216;No Chance Inflation Will Return To 2%&#8217; Without New Rate Hikes</a>
Image created with photos from Shutterstock.

Macro Economic Events

Mid Cap

REIT

Sector ETFs

Bonds

Small Cap

Treasuries

Econ #s

Economics

Federal Reserve

ETFs

Real Estate

ACRE

CMTG

PEAK

iShares FTSE NAREIT Mortgage PLUS Capped Index Fund

XLRE

Sticky Inflation, Surging Treasury Yields Push Mortgage Rates To 2-Month Peak: Real Estate Stocks Tumble

Thursday marks the last chance for investors to receive the next dividend payout from New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 20 cents per share. On Friday, New York Mortgage Trust will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 20 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own NYMT as of the end of Thursday's session are eligible to receive the 20 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 26, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/NYMT">See current stock movements New York Mortgage Trust on Benzinga.</a>

Dividends

New York Mortgage Trust's Ex-Dividend Date Is Friday, Here's What You Need To Know

AIHS

COIN

HOOD

LMFA

LMND

TRUP

Shares of financial stocks are trading lower amid overall market weakness. Also, New York Fed President Williams said the central bank is not discussing rate cuts right now.

Shares of Quanex Building Products Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nx#NYSE">NX</a>) moved lower during Friday&rsquo;s session after the company reported fourth-quarter financial results.
Quanex Building Products shares fell 10.7% to $30.95 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Getaround, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/getr#NYSE">GETR</a>) shares climbed 128.3% to $0.3767 after the company reported a year-over-year increase in third-quarter financial results.</li>
<li>Battalion Oil Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/batl#NYSE">BATL</a>) gained 81.4% to $9.57 after the company announced it will be acquired by Fury Resources.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares climbed 61.7% to $0.2749 after the company and Arrive Technology announced an agreement and plan of merger.</li>
<li>Brilliant Acquisition Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brli#NASDAQ">BRLI</a>) shares gained 60.2% to $10.25.</li>
<li>Elevai Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elab#NASDAQ">ELAB</a>) gained 32.4% to $2.41.</li>
<li>NCS Multistage Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncsm#NASDAQ">NCSM</a>) rose 31.7% to $18.49. NCS Multistage Holdings said that its subsidiary has settled outstanding litigation with Boyd &amp; McWilliams.</li>
<li>iCoreConnect Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icct#NASDAQ">ICCT</a>) surged 31.6% to $1.29.</li>
<li>Verrica Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrca#NASDAQ">VRCA</a>) gained 27% to $4.7764. Verrica Pharmaceuticals&#39; development and commercialization partner Torii Pharmaceutical revealed positive top-line results from confirmatory Phase 3 trial of TO-208 for the treatment of molluscum contagiosum in Japan.</li>
<li>loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) gained 23% to $3.3134.</li>
<li>Netcapital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncpl#NASDAQ">NCPL</a>) shares rose 21.2% to $0.42 following second-quarter results.</li>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) gained 20% to $1.8001. La Rosa Holdings acquired a 100% interest in the company&rsquo;s franchisee - La Rosa Realty CW Properties in Longwood, Florida.</li>
<li>Genius Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gns#NYSE">GNS</a>) rose 19% to $0.7025. Genius Group expects full year 2023 revenue in the range of $27 million-$29 million.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrpx#NASDAQ">VRPX</a>) rose 18.2% to $0.1791 after falling 35% on Thursday.</li>
<li>Near Intelligence, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nir#NASDAQ">NIR</a>) gained 16.3% to $0.0857 after gaining over 5% on Thursday.</li>
<li>Heart Test Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hscs#NASDAQ">HSCS</a>) gained 13.8% to $0.1791 following second-quarter results.</li>
<li>ATN International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atni#NASDAQ">ATNI</a>) rose 13.1% to $38.12. ATN International Board of Directors expanded share repurchase program to $25 million and increased dividend from $0.21 to $0.24 per share.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) surged 10.4% to $9.02.</li>
<li>Context Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntx#NASDAQ">CNTX</a>) gained 9.5% to $1.03.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Chanson International Holding (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chsn#NASDAQ">CHSN</a>) fell 78% to $3.24.</li>
<li>Inno Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inhd#NASDAQ">INHD</a>) shares fell 72.8% to $3.78 after jumping over 246% on Thursday. The company priced its IPO at $4 per share.</li>
<li>Aadi Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aadi#NASDAQ">AADI</a>) shares fell 56.4% to $2.3450 after the company reported interim results from the PRECISION1 trial of nab-sirolimus.</li>
<li>Mangoceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgrx#NASDAQ">MGRX</a>) fell 40.4% to $0.3101 after declining around 10% on Thursday.</li>
<li>Northann Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ncl#NYSE">NCL</a>) fell 40.4% to $6.68.</li>
<li>Aileron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alrn#NASDAQ">ALRN</a>) shares fell 38% to $3.33 after jumping 115% on Thursday.</li>
<li>Eos Energy Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eose#NASDAQ">EOSE</a>) fell 35.8% to $1.0784 after the company reported pricing of $50 million public offering.</li>
<li>Aurora Technology Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atak#NASDAQ">ATAK</a>) fell 26.7% to $7.70.</li>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) fell 25.5% to $2.1522. On Dec 13, Cingulate&#39;s Louis G. Van Horn, Chief Financial Officer, retired from the company.</li>
<li>Freight Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frgt#NASDAQ">FRGT</a>) fell 25% to $0.45. Freight Technologies shares jumped 122% on Thursday after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdt#NASDAQ">CDT</a>) dipped 16% to $6.00.</li>
<li>Scholastic Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/schl#NASDAQ">SCHL</a>) fell 11.8% to $36.59 after the company posted weaker-than-expected results for its second quarter. The company&rsquo;s board also approved an additional $66 million for share repurchases.</li>
<li>New York Mortgage Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nymt#NASDAQ">NYMT</a>) declined 11.5% to $8.48.</li>
<li>Indivior PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indv#NASDAQ">INDV</a>) fell 9.6% to $14.81.</li>
<li>Genelux Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnlx#NASDAQ">GNLX</a>) fell 9.3% to $13.43.</li>
<li>SomaLogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgc#NASDAQ">SLGC</a>) fell 9% to $2.1910. Nautilus Biotechnology filed suit in US District Court against SomaLogic and California Institute of Technology seeking declaratory judgment that the company does not infringe any claims of US Patent No. 7,842,793 related to DNA origami structures.</li>
<li>Hovnanian Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hov#NYSE">HOV</a>) declined 7% to $149.76.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36258073/bitcoin-falls-below-this-key-level-kucoin-token-bittorrent-among-top-losers"> Bitcoin Falls Below This Key Level; KuCoin Token, BitTorrent Among Top Losers</a>

Penny Stocks

Intraday Update

Movers

AADI

ALRN

ATAK

BATL

BRLI

BRSH

CHSN

CING

CNTX

ELAB

EOSE

FRGT

GETR

GNLX

HSCS

ICCT

INDV

INHD

LRHC

MGRX

Nuveen Insured California Premium Fund Ii

NCPL

NCSM

SCHL

SLGC

VRCA

VRPX

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings" target="_blank">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including&nbsp;by analyst accuracy. Here&#39;s a look at the most recent high-yield dividend&nbsp;stock ratings from the most accurate Wall Street analysts, according to Benzinga&#39;s&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock&nbsp;</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Ratings</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3>AGNC Investment Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agnc#NASDAQ">AGNC</a>)</h3>
<ul>
<li>Dividend Yield: 15.78%</li>
<li>Barclays analyst Mark Devries initiated coverage on the stock with an Equal-Weight rating and a price target of $8 on Nov. 15, 2023. This analyst has an accuracy rate of 65%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and cut the price target from $11.75 to $10.5 on April 24, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On Oct. 30, AGNC Investment reported better-than-expected third-quarter adjusted EPS results.</li>
</ul>
<h3>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>)</h3>
<ul>
<li>Dividend Yield: 15.74%</li>
<li>Raymond James analyst Stephen Laws maintained a Strong Buy rating and cut the price target from $9 to $8.5 on Nov. 30, 2023. This analyst has an accuracy rate of 63%.</li>
<li>JMP Securities analyst Steven Delaney maintained a Market Outperform rating and cut the price target from $10 to $9 on Nov. 3, 2023. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Oct. 31, TPG RE Finance Trust posted downbeat third-quarter sales.</li>
</ul>
<h3>New York Mortgage Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nymt#NASDAQ">NYMT</a>)</h3>
<ul>
<li>Dividend Yield: 13.42%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained a Market Perform rating and raised the price target from $10 to $10.25 on May 10, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Maxim Group analyst Michelle Chang maintained a Buy rating and cut the price target from $14 to $13 on May 9, 2023. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On Nov. 1, New York Mortgage Trust posted weaker-than-expected quarterly sales.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/12/36171131/investor-sentiment-rises-further-following-november-jobs-report"> Investor Sentiment Rises Further Following November Jobs Report </a>

Pre-Market Outlook

AGNC

TRTX

Did You Miss These 3 High-Yielding Dividend Stocks In Financial Sector From Wall Street's Most Accurate Analysts?

UBS analyst Douglas Harter initiates coverage on New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) with a Neutral rating and announces Price Target of $8.5.

UBS Initiates Coverage On New York Mortgage Trust with Neutral Rating, Announces Price Target of $8.5

New York Mortgage Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $0.10 by 1140 percent. This is a 21.21 percent increase over losses of $(1.32) per share from the same period last year. The company reported quarterly sales of $16.79 million which missed the analyst consensus estimate of $18.62 million by 9.83 percent. This is a 18.06 percent increase over sales of $14.22 million the same period last year.

New York Mortgage Trust Q3 2023 Gaap EPS $(1.04) Misses $0.10 Estimate, Sales $16.79M Miss $18.62M Estimate

New York Mortgage Trust PFDs: Still Rated Hold As Riskier Than Other mREIT PFDs

Rithm Capital's Updated Sector Comparative Analysis - Part 1 (Includes Recommendation For 19 Peers As Of 9/2/2024)

Gauging Distribution Winners And Losers In The Next Rate Cycle

New York Mortgage Trust declares $0.20 dividend

The High Yield Desert

5 Shares Yielding 8% To 11%

Rithm Capital's Sector Comparative Analysis - Part 2 (Includes Q4 2024 + Q1 2025 Dividend Projection)

Homebuyers return as Fed easing spurs surge in mortgage-rate locks

New York Mortgage Trust Cum Conv Perp Red Pfd Registered Shs Series D goes ex dividend tomorrow

Comments

New York Mortgage Trust

Notizie

Ultime notizie per New York Mortgage Trust (NASDAQ:NYMT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO